| Not Yet Recruiting | A Study (Phase 1b/2) of GenSci134 in Children With Idiopathic Short Stature (ISS) NCT07450053 | Changchun GeneScience Pharmaceutical Co., Ltd. | Phase 1 / Phase 2 |
| Recruiting | Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Childr NCT07221851 | Ascendis Pharma A/S | Phase 3 |
| Recruiting | The Efficacy and Safety of Inpegsomatropin Injection in Children With Idiopathic Short Stature NCT06927310 | Xiamen Amoytop Biotech Co., Ltd. | Phase 3 |
| Recruiting | A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature NCT06382155 | BioMarin Pharmaceutical | Phase 2 |
| Recruiting | A Study to Assess Growth in Children With Idiopathic Short Stature NCT06309979 | BioMarin Pharmaceutical | — |
| Terminated | A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature NCT05894876 | Novo Nordisk A/S | — |
| Not Yet Recruiting | Multidisciplinary Evaluation and a Genome-wide Analysis in a Cohort of Idiopathic Short Stature Patients NCT05858606 | University Hospital, Montpellier | N/A |
| Completed | A Trial of YPEG-rhGH in Children With Short Stature NCT05838885 | Xiamen Amoytop Biotech Co., Ltd. | Phase 2 |
| Recruiting | Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature NCT04798690 | Dong-A ST Co., Ltd. | — |
| Completed | Skeletal Muscle Effects of GH in Boys NCT04020913 | Nemours Children's Clinic | — |
| Unknown | The Impact of the Use of Recombinant Human Growth Hormone on ADHD Characteristics in Children and Adolescents NCT02973061 | Assaf-Harofeh Medical Center | — |
| Withdrawn | Predictive Value of the Insulin-like Growth Factor-1 (IGF-1) Generation Test for the Growth Response to Growth NCT01438801 | Ipsen | Phase 4 |
| Completed | Efficacy and Safety of Recombinant Human Growth Hormone on Height Velocity in Subjects With Idiopathic Short S NCT01778023 | Novo Nordisk A/S | Phase 3 |
| Completed | A Phase 3 Study to Evaluate the Safety and Efficacy of Saizen® in Children With Idiopathic Short Stature (ISS) NCT01746862 | Merck KGaA, Darmstadt, Germany | Phase 3 |
| Completed | Efficacy and Safety of DA-3002 in Children With Idiopathic Short Stature NCT01786902 | Dong-A ST Co., Ltd. | Phase 3 |
| Recruiting | Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children NCT01604395 | LG Chem | — |
| Completed | Short Stature Related Distress NCT01246219 | Rabin Medical Center | Phase 4 |
| Completed | Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers NCT01401244 | Novo Nordisk A/S | Phase 1 |
| Completed | Pharmacodynamics of CNP During Growth Hormone Treatment NCT01504802 | Nemours Children's Clinic | — |
| Completed | Aromatase Inhibitors, Alone And In Combination With Growth Hormone In Adolescent Boys With Idiopathic Short St NCT01248416 | Nemours Children's Clinic | Phase 3 |
| Completed | Genotropin Study Assessing Use of Injection Pen NCT00965484 | Pfizer | Phase 3 |
| Completed | Epidemiology Study on Insulin-like Growth Factor-1 in Children With Idiopathic Short Stature (EPIGROW Study) NCT00710307 | Ipsen | — |
| Completed | Ghrelin Levels in Children With Poor Growth NCT01070173 | Tripler Army Medical Center | — |
| Unknown | A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted Height NCT00840944 | Belgian Study Group for Pediatric Endocrinology | Phase 4 |
| Completed | Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature NCT00396097 | Pfizer | Phase 3 |
| Completed | Biochemical Markers of Growth Response to Growth Hormone Treatment in Children With Idiopathic Short Stature NCT00458263 | Rabin Medical Center | Phase 4 |
| Completed | Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin NCT00488124 | University of Erlangen-Nürnberg Medical School | Phase 2 |
| Terminated | Study to Identify Markers of Insulin Resistance During Growth Hormone Treatment for Short Stature NCT00121875 | Massachusetts General Hospital | — |
| Terminated | Constructing an Insulin-Like Growth Factor-based Prediction Model NCT00263445 | University of California, Los Angeles | — |
| Completed | Safety and Efficacy of Long-term Somatropin Treatment in Children NCT01543867 | Novo Nordisk A/S | — |
| Completed | Effect of Growth Hormone in Children With Growth Hormone Deficiency NCT00262249 | Novo Nordisk A/S | Phase 3 |